Literature DB >> 21367928

Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.

Nicholas A Tritos1, Susan L Greenspan, Donna King, Amir Hamrahian, David M Cook, Peter J Jönsson, Michael P Wajnrajch, Maria Koltowska-Häggstrom, Beverly M K Biller.   

Abstract

CONTEXT: GH deficiency (GHD) is associated with low bone mineral density (BMD). Risk factors for lower BMD in this GHD population have not been fully elucidated. In particular, there are limited published data in GH-naïve subjects.
OBJECTIVE: The objective of the study was to identify endocrine correlates of low BMD in treatment-naïve adult GHD subjects.
DESIGN: This was a retrospective analysis of data extracted from the (Pfizer International Metabolic Study) KIMS database.
SETTING: The study was an international epidemiological survey of more than 15,000 adult GHD patients from 31 countries. PATIENTS: A total of 1218 subjects with stringently defined GHD of adult onset (641 women and 577 men) who were GH naïve and had BMD measured in the posterior anterior lumbar spine and femoral neck by dual-energy X-ray absorptiometry. MAIN OUTCOME MEASURES: Variables associated with standardized BMD (sBMD) in adult-onset GHD were examined.
RESULTS: In the LS, body mass index (r = 0.13, P < 0.01), unreplaced sex steroid deficiency (r = -0.17, P < 0.0001), and corticotropin deficiency (r = -0.11, P < 0.01) were independently associated with sBMD. In the FN, age (r = -0.19, P < 0.0001), female gender (r = -0.18, P < 0.0001), body mass index (r = 0.21, P < 0.0001), and decreased IGF-I SD scores (r = 0.10, P < 0.001) were independently associated with sBMD.
CONCLUSIONS: Hormone variables associated with lower sBMD in patients with adult-onset GHD include unreplaced sex steroid deficiency and corticotropin deficiency in the LS and lower IGF-I SDS in the FN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367928      PMCID: PMC5393425          DOI: 10.1210/jc.2010-2662

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly.

Authors:  Robert D Murray; Breeda Columb; Judith E Adams; Stephen M Shalet
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

2.  Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation.

Authors:  Michele R Hutchison; Mary H Bassett; Perrin C White
Journal:  Endocrinology       Date:  2007-03-29       Impact factor: 4.736

3.  Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.

Authors:  G Zhao; M C Monier-Faugere; M C Langub; Z Geng; T Nakayama; J W Pike; S D Chernausek; C J Rosen; L R Donahue; H H Malluche; J A Fagin; T L Clemens
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

4.  The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

Authors:  C Wüster; R Abs; B A Bengtsson; H Bennmarker; U Feldt-Rasmussen; E Hernberg-Ståhl; J P Monson; B Westberg; P Wilton
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

5.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

Authors:  F Lupu; J D Terwilliger; K Lee; G V Segre; A Efstratiadis
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

6.  Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5.

Authors:  N A Sims; P Clément-Lacroix; F Da Ponte; Y Bouali; N Binart; R Moriggl; V Goffin; K Coschigano; M Gaillard-Kelly; J Kopchick; R Baron; P A Kelly
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 7.  Growth hormone and bone.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

Review 8.  Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency.

Authors:  Giampiero I Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  J Pediatr Endocrinol Metab       Date:  2003-03       Impact factor: 1.634

9.  Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.

Authors:  Georg Brabant; Alexander von zur Mühlen; Christian Wüster; Michael B Ranke; Jürgen Kratzsch; Wieland Kiess; Jean-Marie Ketelslegers; Lars Wilhelmsen; Lena Hulthén; Bernhard Saller; Anders Mattsson; Jürgen Wilde; Rudolf Schemer; Peter Kann
Journal:  Horm Res       Date:  2003

Review 10.  Sex hormones, their receptors and bone health.

Authors:  K Venken; F Callewaert; S Boonen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2008-04-05       Impact factor: 4.507

View more
  10 in total

1.  Effects of testosterone and growth hormone on the structural and mechanical properties of bone by micro-MRI in the distal tibia of men with hypopituitarism.

Authors:  Mona Al Mukaddam; Chamith S Rajapakse; Yusuf A Bhagat; Felix W Wehrli; Wensheng Guo; Helen Peachey; Shane O LeBeau; Babette S Zemel; Christina Wang; Ronald S Swerdloff; Shiv C Kapoor; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

2.  Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - a KIMS database analysis.

Authors:  Nicholas A Tritos; Amir H Hamrahian; Donna King; Susan L Greenspan; David M Cook; Peter J Jönsson; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-05       Impact factor: 3.478

3.  A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Amir H Hamrahian; Donna King; Susan L Greenspan; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  Eur J Endocrinol       Date:  2012-06-18       Impact factor: 6.664

Review 4.  Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis.

Authors:  Gherardo Mazziotti; Andrea G Lania; Ernesto Canalis
Journal:  Nat Rev Endocrinol       Date:  2022-03-14       Impact factor: 43.330

Review 5.  Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.

Authors:  Xin He; Ariel L Barkan
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 6.  Update on vertebral fractures in pituitary diseases: from research to clinical practice.

Authors:  Flaminia Carrone; Salvatore Ariano; Sara Piccini; Davide Milani; Marco Mirani; Luca Balzarini; Andrea Gerardo Lania; Gherardo Mazziotti
Journal:  Hormones (Athens)       Date:  2021-02-19       Impact factor: 2.885

Review 7.  Pituitary disorders and osteoporosis.

Authors:  Marek Bolanowski; Jowita Halupczok; Aleksandra Jawiarczyk-Przybyłowska
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

8.  Multiple Fractures in Patient with Graves' Disease Accompanied by Isolated Hypogonadotropic Hypogonadism.

Authors:  Hyon-Seung Yi; Ji Min Kim; Sang Hyeon Ju; Younghak Lee; Hyun Jin Kim; Koon Soon Kim
Journal:  J Bone Metab       Date:  2016-02-29

9.  Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein.

Authors:  Kosuke Kimura; Tomohiro Terasaka; Nahoko Iwata; Takayuki Katsuyama; Motoshi Komatsubara; Ryota Nagao; Kenichi Inagaki; Fumio Otsuka
Journal:  J Clin Med       Date:  2017-01-05       Impact factor: 4.241

Review 10.  Endocrine Disorder in Patients With Craniopharyngioma.

Authors:  Zihao Zhou; Sheng Zhang; Fangqi Hu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.